BridgeMD
New treatment option for Chronic Migraine
Official title A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
ClinicalTrials.gov ID: NCT06810505
What this study is testing
What is Atogepant?
Atogepant is an investigational medicine, given as an once-daily pill taken by mouth, being studied as a potential treatment for chronic migraine.
Also referred to as Qulipta, Aquipta.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Migraine is a disease that most often causes moderate to severe headache on one side of the head. A migraine attack is a headache that may be accompanied by throbbing, nausea, vomiting, sensitivity to light and sound, or other symptoms.
- Phase 3: a large, late-stage study
- You might receive a placebo (an inactive treatment) instead of the study drug. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 12 to 17
You may be able to join if
- History of chronic migraine with or without aura consistent with a diagnosis according to the International Classification of Headache Disorders, 3rd...
- During the last 28 days of the screening/baseline period, and as per eDiary:
- Participant must have completed the eDiary for a minimum of 20 out of 28 days.
- Participant has \>= 15 headache days.
- Participant has \>= 8 migraine days.
You likely can't join if
- Clinically significant hypertension per investigator's judgment.
- History of any clinically significant hematologic, endocrine, pulmonary, renal, hepatic, gastrointestinal, cardiovascular or neurologic disease.
The study team makes the final eligibility decision.
Where it's taking place
- Huntsville, Alabama, United States
- Fayetteville, Arkansas, United States
- Little Rock, Arkansas, United States
- Anaheim, California, United States
- Fresno, California, United States
- Long Beach, California, United States
- Oceanside, California, United States
- San Jose, California, United States
- Walnut Creek, California, United States
- Gulf Breeze, Florida, United States
- Lakeland, Florida, United States
- Miami, Florida, United States
- Weston, Florida, United States
- Winter Park, Florida, United States
- Evansville, Indiana, United States
- Ann Arbor, Michigan, United States
- Ridgeland, Mississippi, United States
- Papillion, Nebraska, United States
- Nashua, New Hampshire, United States
- Amherst, New York, United States
+ 43 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 12 years to 17 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Huntsville, Alabama, United States; Fayetteville, Arkansas, United States; Little Rock, Arkansas, United States; Anaheim, California, United States; Fresno, California, United States; Long Beach, California, United States and 57 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.